PLIANT THERAPEUTICS, INC.

PLRX · Nasdaq · SIC 2834: Pharmaceutical Preparations
100
SEC Filings

Business Summary

Pliant Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for fibrosis and related diseases. The company develops integrin-based therapeutics, with product candidates targeting fibrotic conditions. Pliant has pursued orphan drug and Fast Track designations for its pipeline and has engaged in research collaborations and license agreements to advance its drug development programs.

Next Earnings

Q2 FY2026 — expected 2026-08-13

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionPLRXdiscussed_in_filing Cybersecurity
topic_mentionPLRXdiscussed_in_filing Trusted Computing
topic_mentionPLRXdiscussed_in_filing Blockchain & Crypto
topic_mentionPLRXdiscussed_in_filing Regulation
topic_mentionPLRXdiscussed_in_filing Healthcare & Bio
topic_mentionPLRXdiscussed_in_filing Platform & Ecosystem
topic_mentionPLRXdiscussed_in_filing Sovereign & Government
topic_mentionPLRXdiscussed_in_filing Cybersecurity
topic_mentionPLRXdiscussed_in_filing Trusted Computing
topic_mentionPLRXdiscussed_in_filing Blockchain & Crypto
topic_mentionPLRXdiscussed_in_filing Regulation
topic_mentionPLRXdiscussed_in_filing Healthcare & Bio
topic_mentionPLRXdiscussed_in_filing Platform & Ecosystem
topic_mentionPLRXdiscussed_in_filing Sovereign & Government
topic_mentionPLRXdiscussed_in_filing Cybersecurity
topic_mentionPLRXdiscussed_in_filing Trusted Computing
topic_mentionPLRXdiscussed_in_filing Blockchain & Crypto
topic_mentionPLRXdiscussed_in_filing Regulation
topic_mentionPLRXdiscussed_in_filing Healthcare & Bio
topic_mentionPLRXdiscussed_in_filing Platform & Ecosystem

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-112025-12-310001746473-26-000037EDGAR79K words
2025-03-032024-12-310001746473-25-000054EDGAR—
2024-02-272023-12-310001746473-24-000043EDGAR—
2023-03-092022-12-310001746473-23-000008EDGAR—
2022-03-012021-12-310001746473-22-000010EDGAR—
2021-03-162020-12-310001564590-21-013589EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-062025-09-300001746473-25-000175EDGAR54K words
2025-08-072025-06-300001746473-25-000150EDGAR—
2025-05-082025-03-310001746473-25-000099EDGAR—
2024-11-072024-09-300001746473-24-000171EDGAR—
2024-08-072024-06-300001746473-24-000145EDGAR—
2024-05-062024-03-310001746473-24-000076EDGAR—
2023-11-092023-09-300001746473-23-000074EDGAR—
2023-08-092023-06-300001746473-23-000053EDGAR—
2023-05-092023-03-310001746473-23-000031EDGAR—
2022-11-082022-09-300001746473-22-000031EDGAR—
2022-08-082022-06-300001746473-22-000027EDGAR—
2022-05-092022-03-310001746473-22-000021EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-300001746473-26-000046EDGAR1K words
2026-03-110001746473-26-000039EDGAR—
2026-03-030001746473-26-000024EDGAR—
2025-12-160001746473-25-000182EDGAR—
2025-12-080001746473-25-000179EDGAR—
2025-11-060001746473-25-000173EDGAR—
2025-10-240001746473-25-000159EDGAR—
2025-10-200001193125-25-243619EDGAR—
2025-08-070001746473-25-000149EDGAR—
2025-06-090001746473-25-000105EDGAR—

100 total filings indexed. 72 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Tags

fibrosis-therapeutics integrin-based-drug-development rare/orphan-diseases

Company Identity

CIK0001746473
TickerPLRX
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 89bef29f203a655759b52437818e05b413a45c26b75a08ad3f5dc8a75c1281d0
parent: 6c67d150c945c0d9c139e0a0e5350c113a27d42ea7d25b9a7f181f112a5c82e8
content hash: e829964aaf325132f12bbabec638b3e9ec4604aa88a4c160e77c89afa2bdb730
signed: 2026-04-13T04:46:55.722Z
sources: 18 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf